Table 1.
Baseline characteristics of patients with primary angle closure, primary angle closure glaucoma and controls included in the study.
Table 2.
Stratification of eyes with primary angle closure based on <25th (strata 1), 25-75th (Strata 2) and >75th (Strata 3) percentile of sum scores of gonioscopic parameters (ACSSg).
Fig 1.
Comparison of sum of gonioscopic scores (ACSSg) with number of baseline medicines required in eyes with primary angle closure (PAC) and primary angle closure glaucoma (PACG)-circles represent outliers.
Fig 2.
Comparison of 4 quadrant (from left to right superior, inferior, temporal and nasal in that order) gonioscopic features of eyes with primary angle closure requiring 0 medicines (a-d) with that requiring 1 medicines (E, F, G and H) or 2 medicines (I, J, K & L and M,N, O &P) showing increasing quadrants of peripheral anterior synecheiae/blotchy pigments/non-visibility of posterior trabecular meshwork and narrower recess with increasing need for number medicines.
Fig 3.
Comparison of 4 quadrant (from above to below superior, nasal, temporal and inferior in that order) gonioscopic features of eyes with primary angle closure glaucoma requiring 0 medicines (group 1-a,d, g and i) with that requiring 1 medicines (group 2-b, e, h and k) or >2 medicines (group 3-c, f, i, l)showing definite differences in gonioscopic features among eyes with different number of medicines, especially group 1 and group 3.
Table 3.
Differences in sum scores of gonioscopic parameters (ACSSg) eyes with primary angle closure (PAC) and primary angle closure glaucoma (PACG) eyes requiring medications after laser iridotomy.
Table 4.
Comparison of clinical and gonioscopic parameters in primary angle closure or primary angle closure glaucoma eyes requiring different number of anti-glaucoma medications after laser iridotomy.